CN Stock MarketDetailed Quotes
900904 Shanghai Shenqi Pharmaceutical Investment Management
- 0.473
- -0.010-2.07%
Market Closed Sep 9 15:00 CST
252.62MMarket Cap29.56P/E (TTM)
0.497High0.471Low1.71KlotVolume0.485Open0.483Pre Close81.81KTurnover0.04%Turnover Ratio31.53P/E (Static)534.07MShares0.78052wk High0.79P/B226.72MFloat Cap0.35652wk Low0.531Limit Up479.32MShs Float2.475Historical High0.435Limit Down5.38%Amplitude-0.004Historical Low0.01Dividend TTM0.478Avg Price1.33KlotAsk2.96%Div YieldTTM100Lot Size365.60lotBid
Shanghai Shenqi Pharmaceutical Investment Management Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.18%961.17M | 1.74%474.66M | -14.32%2.12B | -6.85%1.51B | -0.73%1.05B | -8.07%466.52M | 10.89%2.48B | 8.61%1.63B | 4.48%1.05B | 4.43%507.46M |
| Refunds of taxes and levies | -83.78%405.92K | -99.95%422.14 | -79.99%1.63M | -70.88%2.5M | -66.68%2.5M | -42.82%899.44K | 139.69%8.15M | 338.99%8.6M | 283.71%7.51M | 693,790.14%1.57M |
| Cash received relating to other operating activities | 38.31%131.18M | -43.36%38.34M | 64.30%221.55M | 9.22%149.31M | 11.03%94.84M | 618.66%67.69M | 23.62%134.84M | -4.90%136.71M | -11.39%85.42M | -63.31%9.42M |
| Cash inflows from operating activities | -4.49%1.09B | -4.13%512.99M | -10.48%2.35B | -5.92%1.67B | -0.28%1.14B | 3.21%535.1M | 11.67%2.62B | 7.83%1.77B | 3.59%1.15B | 1.33%518.45M |
| Goods services cash paid | 12.09%392.1M | 31.11%211.54M | -17.69%726.19M | -1.75%545.5M | -7.17%349.81M | -10.59%161.34M | 34.86%882.29M | 28.74%555.21M | 27.52%376.81M | 34.15%180.45M |
| Staff behalf paid | -1.34%100.19M | -2.04%53.62M | 0.27%195.28M | 2.55%147.42M | 6.33%101.55M | 15.63%54.74M | 25.67%194.75M | 28.11%143.76M | 27.84%95.5M | 20.10%47.34M |
| All taxes paid | -28.09%96.47M | -22.52%51.86M | 13.30%231.41M | 29.22%184.46M | 39.80%134.16M | 42.28%66.94M | -2.43%204.25M | -9.55%142.75M | -7.74%95.96M | 4.34%47.05M |
| Cash paid relating to other operating activities | -8.45%381.08M | -33.00%153.16M | -4.18%978.71M | -5.40%622.69M | -11.16%416.25M | 26.43%228.6M | -10.81%1.02B | -20.36%658.25M | -14.73%468.52M | -24.53%180.81M |
| Cash outflows from operating activities | -3.19%969.84M | -8.10%470.19M | -7.43%2.13B | 0.01%1.5B | -3.38%1B | 12.28%511.62M | 6.42%2.3B | -1.83%1.5B | 1.28%1.04B | -0.64%455.65M |
| Net cash flows from operating activities | -13.66%122.91M | 82.28%42.81M | -32.47%215.59M | -38.81%165.5M | 28.72%142.35M | -62.61%23.48M | 73.25%319.23M | 137.05%270.48M | 31.78%110.59M | 18.46%62.8M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | --300K | -82.46%300K | -82.46%300K | ---- |
| Cash received from returns on investments | ---- | ---- | -72.76%463.14K | ---- | ---- | ---- | 0.33%1.7M | 1.42%300K | --300K | -73.24%300K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -89.21%13.86K | -78.50%2.15K | 2,476.41%4.3M | -10.07%137.58K | -16.00%128.42K | -75.02%10K | 37.12%167.06K | 749.94%152.99K | --152.89K | --40.04K |
| Cash inflows from investing activities | -89.21%13.86K | -78.50%2.15K | 119.97%4.77M | -81.73%137.58K | -82.94%128.42K | -97.06%10K | -37.88%2.17M | -62.79%752.99K | -55.97%752.89K | -87.99%340.04K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -24.29%5.77M | -37.21%2.25M | -7.99%24.51M | -48.06%10.91M | -43.61%7.63M | -40.22%3.58M | -69.01%26.64M | -71.98%21M | -77.14%13.52M | -45.82%5.99M |
| Cash paid to acquire investments | ---- | ---- | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --20M | --20M | --20M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -79.10%5.77M | -90.46%2.25M | 67.08%44.51M | 47.17%30.91M | 104.29%27.63M | 293.44%23.58M | -70.09%26.64M | -72.33%21M | -77.14%13.52M | -53.68%5.99M |
| Net cash flows from investing activities | 79.05%-5.76M | 90.46%-2.25M | -62.40%-39.75M | -51.96%-30.77M | -115.33%-27.5M | -316.92%-23.57M | 71.40%-24.47M | 72.59%-20.25M | 77.77%-12.77M | 44.07%-5.65M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --9.8M | --3M | --3M | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --9.8M | ---- | --3M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 35.31%28.22M | -4.01%15.22M | 21.35%28.86M | 269.39%25.86M | 197.96%20.86M | --15.86M | 337.31%23.78M | --7M | --7M | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 181.69%2M | --2M | 5.30%40.09M |
| Cash inflows from financing activities | 18.30%28.22M | -4.01%15.22M | 62.56%38.66M | 220.63%28.86M | 165.08%23.86M | -60.45%15.86M | 191.86%23.78M | 1,167.61%9M | --9M | 5.30%40.09M |
| Borrowing repayment | -18.07%29.51M | -57.59%7.21M | 82.37%74.84M | 92.02%38.02M | 81.91%36.02M | --17M | 10.18%41.04M | 31.55%19.8M | 38.46%19.8M | ---- |
| Dividend interest payment | 66.49%56.98M | -15.81%2.79M | -5.71%66.9M | -4.54%63.87M | 291.43%34.23M | -28.83%3.32M | 1,687.58%70.96M | 2,880.71%66.9M | 459.01%8.74M | 168.80%4.66M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | -69.29%610K | ---- | ---- | ---- | --1.99M | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 28.31%9.52M | 9.40%4.13M | -71.49%13.04M | -72.54%9.75M | -76.95%7.42M | -92.91%3.77M | -14.10%45.72M | 54.44%35.49M | 81.38%32.17M | 16.92%53.2M |
| Cash outflows from financing activities | 23.63%96.01M | -41.34%14.13M | -1.86%154.78M | -8.65%111.63M | 27.92%77.66M | -58.37%24.09M | 67.00%157.72M | 203.39%122.2M | 80.70%60.71M | 16.37%57.86M |
| Net cash flows from financing activities | -25.99%-67.79M | 113.27%1.09M | 13.30%-116.12M | 26.88%-82.77M | -4.05%-53.8M | 53.69%-8.23M | -55.21%-133.93M | -186.09%-113.2M | -53.91%-51.71M | -52.53%-17.77M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | --823.19 | ---- | -76.90%56.85 | ---- | ---- | ---- | 494.72%246.11 | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -19.14%49.37M | 600.49%41.65M | -62.86%59.72M | -62.09%51.95M | 32.41%61.05M | -121.14%-8.32M | 1,198.02%160.82M | 21,125.27%137.03M | 746.40%46.11M | 25.98%39.38M |
| Add:Begin period cash and cash equivalents | 9.12%714.29M | 9.12%714.29M | 32.57%654.57M | 32.57%654.57M | 32.57%654.57M | 32.57%654.57M | 2.57%493.74M | 2.57%493.74M | 2.57%493.74M | 2.39%493.74M |
| End period cash equivalent | 6.71%763.66M | 16.97%755.94M | 9.12%714.29M | 12.01%706.52M | 32.56%715.62M | 21.22%646.24M | 32.57%654.57M | 30.87%630.78M | 13.84%539.85M | 3.82%533.12M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg